Avelox Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Concise Prescribing Info

Contents

Moxifloxacin HCl

Indications/Uses

Acute exacerbations of chronic bronchitis, community-acquired pneumonia, acute sinusitis, uncomplicated skin & skin structure infections, uncomplicated pelvic inflammatory disease (ie, female upper genital tract infections including salpingitis & endometritis), complicated skin & skin structure infections (including diabetic foot infections), complicated intraabdominal infections including polymicrobial infections eg, abscesses.

Click to view Avelox detailed prescribing information

Dosage/Direction for Use

Adult ≥18 yr 400 mg once daily. Duration of treatment: Acute exacerbation of chronic bronchitis 5 days. Community-acquired pneumonia 10 days. Acute sinusitis, uncomplicated skin & skin structure infections 7 days. Uncomplicated pelvic inflammatory disease 14 days. Complicated skin & skin structure infections total treatment duration for sequential therapy (IV followed by oral therapy) 7-21 days. Complicated intra-abdominal infections total treatment duration for sequential therapy (IV followed by oral therapy) 5-14 days.

Click to view Avelox detailed prescribing information

Overdosage

View Avelox overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow tab whole.

Contraindications

Hypersensitivity to quinolones. Childn, growing adolescent. Pregnancy, lactation.

Click to view Avelox detailed prescribing information

Special Precautions

Patients w/ known QT interval prolongation or patients on concomitant medication known to prolong the QTc interval. Uncorrected hypokalemia; ongoing proarrhythmic conditions; seizures, known or suspected CNS disorders which may predispose to seizures or lower the seizure threshold; severe hepatic impairment. Patients on class IA/III antiarrhythmics. Tendon inflammation & rupture may occur. Avoid extensive UV exposure.

Click to view Avelox detailed prescribing information

Use In Pregnancy & Lactation

Click to view Avelox detailed prescribing information

Adverse Reactions

Mycotic superinfections, headache, dizziness, QT prolongation, nausea, vomiting, GI & abdominal complaints, diarrhea, increase in transaminases, inj & infusion site reactions.

Click to view Avelox detailed prescribing information

Drug Interactions

Antacids, minerals, multivit, antiretrovirals (eg, didanosine), sucralfate.

Click to view Avelox detailed prescribing information

Storage

View Avelox storage conditions for details to ensure optimal shelf-life.

Description

View Avelox description for details of the chemical structure and excipients (inactive components).

Action

View Avelox mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Quinolones

ATC Classification

J01MA14 - moxifloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.

Thai FDA Category

Presentation/Packing

Form

Avelox FC tab 400 mg

Packing/Price

5's

Form

Avelox infusion bag 400 mg/250 mL

Packing/Price

1's

Avelox

moxifloxacin

Manufacturer:

Bayer HealthCare Pharma

Distributor:

DKSH